BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11900384)

  • 1. Hyperglycemia-induced protein kinase signaling pathways in vascular smooth muscle cells: implications in the pathogenesis of vascular dysfunction in diabetes.
    Srivastava AK
    Adv Exp Med Biol; 2001; 498():311-8. PubMed ID: 11900384
    [No Abstract]   [Full Text] [Related]  

  • 2. High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes (review).
    Srivastava AK
    Int J Mol Med; 2002 Jan; 9(1):85-9. PubMed ID: 11745003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of PI3K- and MAPK-dependent chemotaxis in aortic vascular smooth muscle cells by protein kinase CbetaII.
    Campbell M; Trimble ER
    Circ Res; 2005 Feb; 96(2):197-206. PubMed ID: 15591231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular smooth muscle cell activation by C-reactive protein.
    Hattori Y; Matsumura M; Kasai K
    Cardiovasc Res; 2003 Apr; 58(1):186-95. PubMed ID: 12667961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can protein kinase C inhibition and vitamin E prevent the development of diabetic vascular complications?
    Bursell SE; King GL
    Diabetes Res Clin Pract; 1999 Sep; 45(2-3):169-82. PubMed ID: 10588370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activation mechanisms of protein kinase Czeta and its cellular function].
    Xu SJ; Cong B
    Sheng Li Ke Xue Jin Zhan; 2005 Oct; 36(4):309-13. PubMed ID: 16408768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
    Touyz RM; Yao G
    J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C in enhanced vascular tone in diabetes mellitus.
    Kizub IV; Klymenko KI; Soloviev AI
    Int J Cardiol; 2014 Jun; 174(2):230-42. PubMed ID: 24794552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p38 mitogen-activated protein kinase is involved in stress-induced phospholipase D activation in vascular smooth muscle cells.
    Min DS; Shin EY; Kim EG
    Exp Mol Med; 2002 Mar; 34(1):38-46. PubMed ID: 11989977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydophila pneumoniae induces ICAM-1 expression in human aortic endothelial cells via protein kinase C-dependent activation of nuclear factor-kappaB.
    Vielma SA; Krings G; Lopes-Virella MF
    Circ Res; 2003 May; 92(10):1130-7. PubMed ID: 12714566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II regulation of the Na+ pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells.
    Isenovic ER; Jacobs DB; Kedees MH; Sha Q; Milivojevic N; Kawakami K; Gick G; Sowers JR
    Endocrinology; 2004 Mar; 145(3):1151-60. PubMed ID: 14630723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin A upregulates ETB receptor in vascular smooth muscle via activation of mitogen-activating protein kinases and NF-κB pathways.
    Zheng JP; Cheng Z; Jiang J; Ke Y; Liu Z
    Toxicol Lett; 2015 May; 235(1):1-7. PubMed ID: 25772258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms for early microvascular injury in obesity and type II diabetes.
    Bohlen HG
    Curr Hypertens Rep; 2004 Feb; 6(1):60-5. PubMed ID: 14972096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of MAPK by modified low-density lipoproteins in vascular smooth muscle cells.
    Velarde V; Jenkins AJ; Christopher J; Lyons TJ; Jaffa AA
    J Appl Physiol (1985); 2001 Sep; 91(3):1412-20. PubMed ID: 11509543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Proliferative Effects of Rutin on OLETF Rat Vascular Smooth Muscle Cells Stimulated by Glucose Variability.
    Yu SH; Yu JM; Yoo HJ; Lee SJ; Kang DH; Cho YJ; Kim DM
    Yonsei Med J; 2016 Mar; 57(2):373-81. PubMed ID: 26847289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of sphingosine kinase-1 mediates inhibition of vascular smooth muscle cell apoptosis by hyperglycemia.
    You B; Ren A; Yan G; Sun J
    Diabetes; 2007 May; 56(5):1445-53. PubMed ID: 17325258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin stimulates VEGF release via p44/p42 MAP kinase in vascular smooth muscle cells.
    Takenaka M; Hirade K; Tanabe K; Akamatsu S; Dohi S; Matsuno H; Kozawa O
    Biochem Biophys Res Commun; 2003 Jan; 301(1):198-203. PubMed ID: 12535662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superoxide dismutase and catalase inhibit oxidized low-density lipoprotein-induced human aortic smooth muscle cell proliferation: role of cell-cycle regulation, mitogen-activated protein kinases, and transcription factors.
    Lin SJ; Shyue SK; Shih MC; Chu TH; Chen YH; Ku HH; Chen JW; Tam KB; Chen YL
    Atherosclerosis; 2007 Jan; 190(1):124-34. PubMed ID: 16600249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grape seed proanthocyanidins attenuate vascular smooth muscle cell proliferation via blocking phosphatidylinositol 3-kinase-dependent signaling pathways.
    Wang L; Zhu LH; Jiang H; Tang QZ; Yan L; Wang D; Liu C; Bian ZY; Li H
    J Cell Physiol; 2010 Jun; 223(3):713-26. PubMed ID: 20175116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation.
    Li L; Sawamura T; Renier G
    Circ Res; 2004 Apr; 94(7):892-901. PubMed ID: 15001526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.